Office Based Addiction Treatment Training and Technical Assistance (OBAT TTA)

A Resource for Healthcare and Social Services Professionals

Training

Back to calendar

Back to event list

Event summary

Buprenorphine Waiver Training for ED Providers

This event is intended to provide eight hours of required training for ED providers seeking their buprenorphine waivers

Event details

Description

This eight-hour course prepares physicians, nurse practitioners and physician assistants to prescribe buprenorphine to treat opioid use disorder in their office. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient's other medical needs in an office setting such as a primary care clinic. The course fulfills 8 hours of the training needed to obtain a waiver to prescribe buprenorphine. The Drug Addiction Treatment Act of 2000 (DATA 2000) requires physicians to complete 8 hours of approved training in order to be eligible for a waiver, and nurse practitioners and physician assistants to complete 24 hours.

Check-in for the course will be from 8:00am-8:30am, and the course will run from 8:30am-4:30pm.

Free parking is available on site.

This is an in-person training. There will not be an option to attend via webinar.

For questions the day of the event, please call Colleen LaBelle at 617-797-6712.

Objectives

Upon completion of this 8 hour training, the participants will be able to:

Intended audience

ED providers: MDs, PAs, and NPs

Sponsored by

Sponsored By

Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS). 


American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this training.

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA.  The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government

Accreditation information

CME Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAP and the Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health and the Bureau of Substance Abuse Services (DPH/BSAS). AAAP is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: American Academy of Addiction Psychiatry designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Method of physician participation in the learning process: Credit will only be awarded for completing all of the training. To be awarded a maximum of 8 AMA PRA Category 1 Credits™ and a Buprenorphine Training Completion Certificate you must complete all 8 hours of the course. Those completing the course will be able to complete the waiver application online.